I would like to point out that in many cases it is not so much that Cornell is killing the share price or the company, but that Cornell was the last financing option for a company already doomed.
In many cases, not necessarily most.
In those cases, Cornell's involvement tells us that the company cannot raise decently priced capital, and that's because their intrinsic value doesn't warrant decently priced capital, regardless of what management might say.